Trial will evaluate the safety and efficacy of histotripsy against liver tumors at eight U.S. sites.

The liver siphons critical immune cells to render immunotherapy ineffective; radiation to the liver may block this process.

A hepatologist comments on the new USPSTF guidelines for detecting hepatitis B in non-pregnant adults and adolescents. 

An international team of researchers conducts a study that defines a simple, low-cost blood test that yields high-performing results in the elimination of hepatitis C.

A collaborative U-M team shows that liver injury is less likely to originate from popular cancer immunotherapy drug, pembrolizumab, than tumor progression.

U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.